AC
OGN icon

Aristeia Capital’s Organon & Co OGN Stock Holding History

Aristeia Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,550
Closed -$162K – 758
2025
Q4 		$162K Buy
+22,550
New +$178K ﹤0.01% 434
2024
Q4 		– Sell
-13,172
Closed -$252K – 426
2024
Q3 		$252K Buy
+13,172
New +$273K 0.01% 235
2024
Q2 		– Sell
-13,104
Closed -$246K – 373
2024
Q1 		$246K Buy
+13,104
New +$225K 0.01% 159

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Aristeia Capital's OGN Position: Q1 2026 in Review

Aristeia Capital sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 22,550 shares — an estimated $162K sold.

Aristeia Capital first reported a position in OGN in Q1 2024 and held it in 3 quarters. The position peaked at $252K in Q3 2024. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Aristeia Capital reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Aristeia Capital sold 22,550 Organon & Co shares in Q1 2026, an estimated $162K.
  • Aristeia Capital first reported a position in Organon & Co in Q1 2024 and held it in 3 quarters.
  • Aristeia Capital's Organon & Co position peaked at $252K in Q3 2024.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.